À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾½«»ý¼«Îª±»ºöÊÓµÄÈÈ´ø²¡ºÍű¼²¿ª·¢ÐÂÒ© £¬²¢ÎªÈ«Çò½¡¿µ¼¼ÊõÕñÐË»ù½ðµÚÈý½×¶ÎÌṩ×ʽðÖ§³Ö

À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÌåÏÖ £¬½«Ïò¹«ÒæÉçÍÅ·¨ÈËÈ«Çò½¡¿µ¼¼ÊõÕñÐË»ù½ð£¨Global Health Innovative Technology Fund£©ÎªÆÚÎåÄ꣨×Ô2023ÄêÖÁ2027Ä꣩×ܼÆ6.25ÒÚÈÕÔªµÄµÚÈýÆÚ»ù½ð ¡£GHIT Fund½¨Á¢ÓÚ2013Äê4Ô £¬ÓÉ°üÂÞÀ´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÔÚÄÚµÄÈÕ±¾ÖÆÒ©ÆóÒµ¡¢ÈÕ±¾¹úÕþ¸®¡¢±È¶ûºÍ÷Áմ¸Ç´Ä²ÆÍŵȺÏ×÷»ï°éÅäºÏÉèÁ¢ £¬Ö¼ÔÚ´Ù½øÈÕ±¾ºÍº£ÍâÑо¿»ú¹¹µÄºÏ×÷ £¬¼ÓËÙÑз¢Õë¶ÔÉú³¤Öйú¼ÒºÍÐÂÐ˹ú¼ÒµÄѬȾ²¡µÄ´´ÐÂÒ©Îï ¡£À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÒÑÏòGHIT FundÌṩµÚÒ»ÆÚ£¨2013 – 2017Äê¶È£©ºÍµÚ¶þÆÚ£¨2018 – 2022Äê¶È£©»ù½ð¹²¼Æ10ÒÚÈÕÔªµÄ×ʽðÖ§³Ö ¡£

ÔÚÉú³¤Öйú¼ÒºÍÐÂÐ˹ú¼Ò £¬Ñз¢ÁÕßÍ´¿àµÄÈÈ´ø² ¡£¨NTDs£©ºÍű¼²µÈѬȾ²¡ÁìÓòµÄÐÂҩʱ £¬³ýÁ˼²²¡ÌØÓеÄÀ§ÄÑÓëÊг¡ÐԵȿÎÌâÖ®Íâ £¬È·±£µ±µØµÄ¹©Ó¦ÌåϵÓëÕïÖεĿɼ°ÐÔÒ²ÊǺÜÒªº¦µÄ ¡£Òò´Ë £¬¿Ë·þÕâЩÌôÕ½µÄÒªº¦¾ÍÊÇ¿çÐÐÒµµÄºÏ×÷ £¬¼´ÆóÒµ½ç-Õþ¸®-ѧÊõ½çµÄºÏ×÷»ï°é¹Øϵ ¡£

À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÊÓ½â¾öÈ«ÇòÒ©Æ·¿É¼°ÐÔÎÊÌâΪ¼ºÈÎ £¬ÔÚ°üÂÞÕþ¸®¡¢¹ú¼Ê×éÖ¯ºÍ˽Ӫ·ÇÓªÀû×éÖ¯ÔÚÄڵĹ«Ë½»ï°éºÏ×÷¹ØϵÏ £¬À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾¼ÓÈëÁË23¸öÁªºÏÑо¿ÏîÄ¿ £¬²¢ÔÚGHIT FundµÄÖ§³ÖÏÂÑз¢ÖÎÁÆ×ã¾úÖס¢Å±¼²ºÍË¿³æ²¡µÄÐÂÒ©ºÍÒßÃç ¡£À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾Óë·ÇÓªÀû×éÖ¯¡°±»ºöÊÓ¼²²¡Ò©ÎﳫÒ顱£¨DNDi£©ºÏ×÷ £¬ÔÚËÕµ¤¿ªÕ¹ÆäÔ­ÑÐÖÎÁÆ×ã¾úÖ×Ò©ÎïIIÆÚÁÙ´²ÊÔÑ顪¡ªE1224£¨Í¨ÓÃÃû£ºfosravuconazole£© ¡£À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾»¹Óë¿ÏËþ»ù´óѧºÏ×÷¿ªÕ¹¿¹Å±Ò©SJ733µÄIIÆÚÁÙ´²ÊÔÑé ¡£

À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾ÈÏΪ £¬¶Ô±»ºöÊÓµÄÈÈ´ø²¡ºÍű¼²µÈÒ©Æ·µÄÑз¢ÓëÒ©Æ·¿É¼°ÐԵĸÄÉÆ £¬¶¼ÊÇÇкÏÀ´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾¡°ÌåÌùÈËÀཡ¿µ¡±£¨hhc £¬human health care£©µÄÆóÒµÀíÄî £¬µÞÔìºã¾ÃÆóÒµÉç»á¼ÛÖµºÍÓ°ÏìµÄ»î¶¯ ¡£À´Àû¹ú¼Êw66¹Ù·½ÍøÕ¾½«¼ÌÐø¼ÓÇ¿ÓëÈ«Çò»ï°éµÄºÏ×÷ £¬Îª¼õÇáÃæÁÙ±»ºöÊÓµÄÈÈ´ø²¡Ñ¬È¾·çÏÕµÄÈ˶Խ¡¿µµÄ½¹ÂǺÍËõС»¼ÓÐÕâЩ¼²²¡»¼ÕߵĽ¡¿µ²î¾à £¬×ö³öТ¾´ ¡£

 

Media Inquiries:
Public Relations Department,
Eisai Co., Ltd.
+81-(0)3-3817-5120